Perrigo has signed a definitive merger agreement as well as has acquired Cobrek Pharmaceuticals, an US-based drug development company, for nearly $45m on a cash free and debt free basis. The company, in May 2008, had also acquired an ...
Tags: Perrigo, definitive merger agreement, Cobrek Pharmaceuticals